- Non-dilutive 50,000 CHF cash grant
- 12 months of personalized support valued at up to 50,000 CHF – tailored to the specific needs of each company (fractional roles, domain expertise, operational guidance, etc.)
- Relocation and settlement support of up to 5,000 CHF, covering legal advice, notary fees or other direct costs of relocation
- Support in accessing the Basel Incentive Programme (up to 25% cash back on R&D costs and up to 50% of lab rental costs)
- 12 months of desk space at a Switzerland Innovation Park Basel Area (preference for Novartis Campus)
- Leveraging the full DayOne network and expertise – gaining long-term access to mentors, industry experts and investors
- Preferred access to conferences and visibility opportunities
Welcome to DayOne NEXT
DayOne NEXT is a long-term support program designed to help the most promising startups from the DayOne accelerator cohort build, scale and anchor their R&D in the Basel Area.
DayOne NEXT is designed around a simple idea: early-stage healthtech, techbio and pharma-enabling ventures need more than short-term momentum. They need time, focus, ecosystem integration and highly tailored support. We will work side-by-side with a small number of exceptional founders and actively help build the company.
Program benefits - funding, mentorship and more
Note: DayOne NEXT candidates are selected following the annual accelerator program (from the cohort group).
How healthtech startups are transforming Pharma R&D through acceleration: DayOne accelerator program testimonials